JEREMIAH ELLINGSWORTH: Open Payments
NPI 1992268437 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$970 in 38 payments from 14 companies in 2025. Trend: 2023 $373 · 2024 $508 · 2025 $970
Food & beverage: $970
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $192 |
| Vanda Pharmaceuticals Inc. | 4 | $145 |
| HARMONY BIOSCIENCES LLC | 4 | $114 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $89 |
| Otsuka America Pharmaceutical, Inc. | 3 | $88 |
| Axsome Therapeutics, Inc. | 3 | $78 |
| Janssen Pharmaceuticals, Inc | 2 | $60 |
| Alkermes, Inc. | 2 | $41 |
| JAZZ PHARMACEUTICALS INC. | 1 | $36 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
Products named: VRAYLAR, FANAPT, WAKIX, CAPLYTA, REXULTI, SPRAVATO, Auvelity, XYWAV.
Industry payments across IN — which companies pay providers there.
